Stanford school of Medicine

Stanford, California 94305-5826

5 studies enrolling now · 14 studies all time

What they study most

AML, Adolescent Congenital Heart Disease, Advance Directives, CYP2C19 Genetic Variants, Coronary Artery Disease, Endometrial Neoplasms, Epidermolysis Bullosa, Epidermolysis Bullosa Dystrophica, Graft Versus Host Disease, MDS, Major Depressive Disorder (MDD), Mental Well-being

Studies at this site

• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study — Recruiting now
• CYP2C19 Variants and Limonene Metabolism — Recruiting now
• Comparing the Stanford Letter Project Form to Traditional Advance Directives — Recruiting now
• Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations — Starting soon
• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer — Running, not enrolling
• Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin — Stopped early
• ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study — Completed
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer — Completed
• Genomics Used to Improve DEpression Decisions — Completed
• Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) — Completed
• Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement — Status unconfirmed
• Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care — Completed